Heart cancels tour due to Ann Wilson's cancer diagnosis

In a recent announcement, lead singer Ann Wilson of the iconic rock band Heart revealed that she will be undergoing cancer treatment, leading to the postponement of the band's ongoing Royal Flush Tour. Wilson, 74, shared that she had a successful operation to remove a cancerous growth and is now advised to undergo preventative chemotherapy, prompting her decision to take a break from performing for the remainder of the year to focus on her recovery. Despite this setback, Wilson expressed her intention to return to the stage in 2025 and assured fans that this pause is temporary, with rescheduled tour dates to be announced in the near future. The Royal Flush Tour, which kicked off in April and was set to conclude in December, will be rescheduled to accommodate Wilson's treatment and recovery timeline. The band, including Wilson's sister Nancy Wilson on guitar, made the difficult decision to postpone over 50 shows across the U.S. and Canada, impacting fans who had purchased tickets for the upcoming performances. The postponed shows were expected to feature special guest appearances from bands like Def Leppard and Journey, although it remains unclear if these collaborations will carry over to the rescheduled dates. Heart had previously canceled the European leg of their tour in May due to a time-sensitive medical procedure for Wilson, emphasizing the importance of her health and well-being. The Wilson sisters, known for hits like "Magic Man" and "Crazy on You," have been making music together since the 1970s and were honored with a lifetime achievement award from the Recording Academy in 2023. As fans await further updates on the rescheduled tour dates, the band's loyal supporters have shown an outpouring of support for Ann Wilson during this challenging time, wishing her a speedy recovery and eagerly anticipating her return to the stage in the future.